Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645612.RATMJ_zlk0tny50QpJ2bgFPohzDqcjNCiDhlLejsGbiL4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645612.RATMJ_zlk0tny50QpJ2bgFPohzDqcjNCiDhlLejsGbiL4130_assertion type Assertion NP645612.RATMJ_zlk0tny50QpJ2bgFPohzDqcjNCiDhlLejsGbiL4130_head.
- NP645612.RATMJ_zlk0tny50QpJ2bgFPohzDqcjNCiDhlLejsGbiL4130_assertion description "[Given the importance of MRP1 overexpression in neuroblastoma, MRP1 inhibition may be a clinically relevant approach to improving patient outcome in this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645612.RATMJ_zlk0tny50QpJ2bgFPohzDqcjNCiDhlLejsGbiL4130_provenance.
- NP645612.RATMJ_zlk0tny50QpJ2bgFPohzDqcjNCiDhlLejsGbiL4130_assertion evidence source_evidence_literature NP645612.RATMJ_zlk0tny50QpJ2bgFPohzDqcjNCiDhlLejsGbiL4130_provenance.
- NP645612.RATMJ_zlk0tny50QpJ2bgFPohzDqcjNCiDhlLejsGbiL4130_assertion SIO_000772 18085475 NP645612.RATMJ_zlk0tny50QpJ2bgFPohzDqcjNCiDhlLejsGbiL4130_provenance.
- NP645612.RATMJ_zlk0tny50QpJ2bgFPohzDqcjNCiDhlLejsGbiL4130_assertion wasDerivedFrom befree-2016 NP645612.RATMJ_zlk0tny50QpJ2bgFPohzDqcjNCiDhlLejsGbiL4130_provenance.
- NP645612.RATMJ_zlk0tny50QpJ2bgFPohzDqcjNCiDhlLejsGbiL4130_assertion wasGeneratedBy ECO_0000203 NP645612.RATMJ_zlk0tny50QpJ2bgFPohzDqcjNCiDhlLejsGbiL4130_provenance.